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Abstract
Background and Objective: This paper presents BRAIM, a computer-aided
diagnosis (CAD) system to help clinicians in diagnosing and treatment mon-
itoring of brain diseases from magnetic resonance image processing. BRAIM
can be used for early diagnosis of neurodegenerative diseases such as Parkinson,
Alzheimer or Multiple Sclerosis and also for brain lesion diagnosis and moni-
toring. Methods: The developed CAD system includes different user-friendly
tools for segmenting and determining whole brain and brain structure volumes
in an easy and accurate way. Specifically, three types of measurements can be
performed: (1) total volume of white, gray matter and cerebrospinal fluid; (2)
brain structure volumes (volume of putamen, thalamus, hippocampus and cau-
date nucleus); and (3) brain lesion volumes. Results: As a proof of concept,
some study cases were analyzed with the presented system achieving promising
results. In addition to be used to quantify treatment effectiveness in patients
with brain lesions, it was demonstrated that BRAIM is able to classify a sub-
ject according to the brain volume measurements using as reference a healthy
control database created for this purpose. Conclusions: The CAD system
presented in this paper simplifies the daily work of clinicians and provides them
∗Corresponding author
Email address: sanmomar@i3b.upv.es (Sandra Morales)
Preprint submitted to Computer Methods and Programs in Biomedicine April 18, 2017
with objective and quantitative volume data for prospective and retrospective
analyses.
Keywords: Magnetic Resonance Imaging; Volumetric analysis; CAD; Brain
segmentation; Brain lesions;
1. Introduction
Neurological disorders are one of the most common health problems of the
population that negatively affect their individual autonomy and well-being. Be-
sides the physiological aging and natural cognitive decline, numerous diseases
such as Parkinson disease, Multiple Sclerosis, and many common processes in
the adult population (i.e. infections, neoplasms, systemic diseases, drug con-
sumption, etc.) can adversely affect cognitive functions both acute or chronically
[1, 2]. Regardless etiology, in all cases an early diagnosis is crucial to proceed
with appropriate therapeutic measures in order to improve patients quality of
life and/or moderate the development of clinical complications [3, 4, 5].
In the clinical setting, recent studies have highlighted the relevance of per-
forming volumetric measurements instead of the classical approach of qualitative
analyses. For example, in neurodegenerative disorders researchers have shown
that early brain atrophy detection (which is not possible by visual inspection
of the MR images) is extremely valuable for early diagnosis and better patient
management [6, 7, 8]. In oncology, accurate volume tumor measurements are
a critical indicator of disease progression and/or treatment efficacy. Particu-
larly, when assessment methods use robust tumor volume measurements, the
obtained information constitutes the most important predictor of patient out-
come [9, 10, 11].
However, and despite the proven clinical relevance of brain volumetric anal-
yses, this technique is not usually performed in the clinical setting. The main
reasons are that it is somewhat tedious and time-consuming, needs special-
ized personnel, a suitable software, and a specific Magnetic Resonance Imaging
(MRI) protocol [12, 13].
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Additionally, and despite the fact that the process a priori seems quite sim-
ple, there are not adequate or user-friendly tools available for clinicians at the
moment. There are many applications that help the process and are able to
brain segmentation, but in most cases their use and installation are complex
requiring the installation of many other data libraries as well as computation
skills. Besides, most of the available software for brain segmentation are black
boxes that provide automatic segmentation results not allowing any type of
amend or adjustment if the results are not satisfactory. In general, this type of
procedure works accurately in healthy brains but frequently fails in the pres-
ence of lesions, significant brain atrophy or anatomical variations. Therefore, in
clinical studies it is very common that some pathological cases must be removed
from the investigation despite the image acquisition was adequate; because the
automatic segmentation provided by the software is not correct.
In this paper, we present a new computer-aided diagnosis (CAD) system for
clinicians. BRAIM is a software tool capable to perform brain segmentation and
robust volumetric analyses. It could be operated in a common PC with Windows
operating system and does not require any specific computing skills to use it.
It allows semi-automated and automated segmentation of the brain and its
structures, as well as manual correction of the segmentation results in case they
are not optimal. In addition, it is featured with an internal MRI database from
healthy controls that can be continuously upgraded by the operator. Making
use of this control database, the system is able to classify the patient status
according to the segmentation results. As it will be shown in the next sections
BRAIM CAD system offers many advantages for clinicians as it could be easily
used in the clinical setting, it is fast, user-friendly and intuitive.
The paper is organized as follows: first, materials and methods are described.
Secondly, a description in depth of the functionalities of the CAD system pre-
sented in the paper is included. Next section presents some results to demon-
strate the software usefulness. Finally, discussion, conclusion and some future
work areas are provided.
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2. Materials and methods
2.1. Subjects
In order to test and validate the software, several brain MRI studies were
obtained. Candidate selection was performed as follows.
2.1.1. Healthy subjects
50 healthy subjects (25 male, 25 female; mean age 44.14 ± 14.2; range 22-70
years) were included in the study and used to create a control database. In order
to ensure a homogenous distribution of the data base results, ten subjects were
included for each decade of age (5 males, 5 females). Subjects were recruited
from the department of Neurology at the “Hospital Universitario de Alicante”
by an experienced Neurologist. Suitability of participants as healthy controls,
was ensured after clinical history and cognitive and physical examination. In
addition each participant performed two cognitive test, specifically the SDMT
(symbol digit modality test) [14] and the T@M memory test [15]. Both tests
were used to rule out any cognitive problem that could negatively affect the
investigation. Exclusion criteria included claustrophobia, metal implants, visual
or neurological disease, epilepsy, drug abuse, psychiatric disease, head injury or
any other conditions that could negatively affect the subject cognition.
2.1.2. Patient selection
Patients included in this paper as examples are part of a bigger study
(BRAIM project, www.i3b.webs.upv.es/cvblab/en/braim-2/) and were se-
lected by specialized clinicians from the departments of Neurology and Neu-
rosurgery both located in the “Hospital Universitario de Alicante”, Spain. In
particular, four patients were selected to illustrate the BRAIM functioning:
• Patient A: a 47 year-old female patient diagnosed with Multiple Sclerosis
subtype remitent-recidivant for eleven years. Neurological tests suggested
mild cognitive impairment with SDMT score of 27 (normative value ≥ 42
[14, 16, 17]) and T@M results of 41 (cut-off value in elderly population
>37 [18, 19]).
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• Patient B: a 48 year-old female patient diagnosed with Multiple Sclerosis
subtype remitent-recidivant for fourteen years. Neurological tests did not
suggest cognitive impairment with SDMT score of 42 (normative value ≥
42 [14, 16, 17]) and T@M results of 49 (cut-off value in elderly population
>37 [18, 19]).
• Patient C: a 25 year-old female diagnosed with a pontine tumor. Biopsy
was not performed because of the lesion location. Chemotherapy was
administrated in order to control tumor growth.
• Patient D: a 27 year-old male diagnosed with brain astrocitoma III. The
lesion affected both frontal lobes and corpus callosum. After surgery
chemotherapy and radiotherapy were administrated to the patient in order
to control the rest tumor growth.
The protocol was approved by the institutional review board and the “Agen-
cia Espan˜ola del Medicamento y Productos sanitarios” (www.aemps.gob.es).
All participants were informed about the study and gave their written informed
consent prior to entering the study.
2.2. MRI protocol
MRI studies were performed on a 3T Philips Achieva with a SENSE Neu-
rovascular coil 16 elements provided by the manufacturer (Philips, The Nether-
lands). The MRI protocol consisted of a high-resolution T1-weighted turbo
gradient-echo scan: 160 slices, 1 mm isotropic voxels, field of view 250 x 250
mm, TR 13 ms and TE 7 ms, Flip angle 8◦ in axial plane. In the case of brain
tumor, images were acquired after contrast injection (Gadovist, 0.1 mg/kg).
After acquisition, all images were transferred to a workstation (Philips, The
Netherlands) and checked by an experienced radiologist to ensure the absence
of artifacts or any brain lesions that could negatively affect the study.
2.3. Volumetric measurements and MRI analyses
The MRI studies of the 50 healthy selected subjects were analyzed with
BRAIM software. After skull striping, automated segmentation of white mat-
5
ter, gray matter and CSF was performed. These automatic segmentation results
were saved and semi-automatic segmentation was performed for both thala-
mus, hippocampus, caudate nucleus and putamen. Afterwards, volume of the
segmented tissues and structures were computed and the results were added
progressively to the database taking into account the age of the patient.
MRI of Multiple Sclerosis patients (Patient A and B) were also analyzed
with BRAIM software following the same procedure as described previously
and the obtained values were introduced in the classification system for patient
comparison within de database.
In the case of brain tumor images (Patient C and D), only the lesion was
segmented by automatic procedures with BRAIM software and manual editing
was performed afterwards if necessary.
2.4. Statistical analyses
All statistical analyses were performed using SPSS Version 19.0 (SPSS Inc.,
Chicago, IL). Results are expressed as mean ± standard deviation. We used the
Kolmogorov-Smirnoff test for determining the normal distribution of the data.
Two different Paired Student t-tests were performed to compare volumetric data
results: a t-test to compare interhemispheric volumetric data for basal ganglia,
thalamus and hippocampus structures; a second t-test was performed to assess
differences in white matter, gray matter and cerebrospinal fluid between sexes.
A p value < 0.05 was considered statistically significant.
2.5. System requirements
BRAIM software is a program written in C/C++ compiled for Windows
platforms. It was developed making use of several open-source libraries: Qt
4.8.1 (www.qt.io/) for graphical user interface creation; Insight Segmentation
and Registration ToolKit (ITK 3.20, itk.org/) for image analysis; Visualization
ToolKit (VTK 5.10, www.vtk.org/) for 3D rendering and representation; and
Statistical Parametric Mapping (SPM12, www.fil.ion.ucl.ac.uk/spm/) for
neuroimaging data analysis. SPM is a suite of MATLAB (The MathWorks,
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Inc.) functions that were compiled with MATLAB Compiler toolbox 7.16. The
use of the functions belonging to these libraries is combined along with own
algorithms.
BRAIM is available for Windows (XP/Vista/Windows 7/Windows 10). All
the required libraries were embedded in the tool installer and do not require
commercial licenses for research purposes. It requires less than 1.2 GB of free
hard disk space for its installation (260 MB for BRAIM and 898 MB for MAT-
LAB Compiler Runtime).
3. CAD system description
The goal of the CAD system presented in this paper is to analyze the volume
of specific brain regions including structures and lesions from a 3D brain MRI.
In Figure 1, the BRAIM architecture is depicted. The aspect of its graphical
user interface can be observed in Figure 2. Note that tissue segmentation,
i.e. white matter, gray matter and cerebrospinal fluid segmentation, and skull-
stripping are performed making use directly of SPM software package; structure
segmentation is implemented by means of an interactive polygon tool designed
in BRAIM; and lesions are segmented by own algorithms.
Figure 1: Schematic representation of BRAIM architecture.
BRAIM software is designed to be used in the daily work of clinicians, so
it works on DICOM images. BRAIM is able to load and work not only MRI
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Figure 2: BRAIM graphical user interface. The main components are shown, the menu bar
(magenta), visualization windows (cyan) and panels (yellow).
but also other medical image modalities as long as they are in DICOM format.
However, as the main objective of this software is to study the brain in a high-
resolution detail as well as to perform accurate volumetric analyses, MRI is
the proper modality for this purpose; it has a great range of available soft
tissue contrast, depicts anatomy in great detail and is sensitive and specific for
abnormalities within the brain itself.
When a brain MRI is loaded, the anatomic study is represented in axial,
sagittal and coronal view (Figure 2, right). The software loads the main plane
(usually axial) and interpolates the other missing planes (usually coronal and
sagittal). This allows to a better perception of the brain structures and/or
lesions to be segmented. If it is needed, a 3D view of the brain can also be
generated.
Later, the main actions of the software are enabled (Figure 2, left). Next,
8
they will be described in depth. The main functions and libraries used for their
implementation are detailed in Appendix A.
3.1. Visualization options
A Window/Level function can be applied, if it is needed, to enhance the
image contrast and brightness and improve the visualization of the brain and its
structures. This function applies a linear gray-scale transformation by means of
a lookup table (LUT) specified by window (W) and level (L) parameters. These
parameters define a specific range of gray level intensities to be highlighted.
The gray level intensities outside the range are transformed to the minimum or
maximum value of the range, as applicable.
3.2. Brain tissue segmentation
Total white matter (WM), gray matter (GM) and cerebrospinal fluid (CSF)
are automatically segmented using SPM software package (SPM12, www.fil.
ion.ucl.ac.uk/spm/). SPM defines the tissue types according to probability
maps obtained through a modified Gaussian Mixture Model [20]. A Gaussian
mixture model is a parametric probability density function represented as a
weighted sum of Gaussian component densities.
A distribution can be modelled by a mixture of K Gaussians (clusters) where
each cluster k is described by its number of voxels (hk), mean (vk) and variance
(ck). In particular, SPM is based on a Bayesian formulation of the Gaussian
mixture model with a prior probability image obtained by averaging an already
segmented large number of brain images. Based on the prior probability of each
voxel belonging to a specific tissue type, the Bayesian framework is used to
get the posterior probability. Let F be an image of I × J voxels, the posterior
probability pijk that a voxel (i,j) belongs to cluster k given its intensity of fij




over i = 1...I, j = 1...J and k = 1...K, (1)
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where rijk is the likelihood of a voxel in cluster k having an intensity of fij , and
sijk is the a priori probability of voxel (i,j) belonging in cluster k.
The likelihood function is obtained by evaluating the probability density










over i = 1...I, j = 1...J and k = 1...K,
(2)
being U a modulation function that represents the intensity and noise associated
with each voxel in the image by multiplication with a smooth scalar field and
uij the particular multiplicative correction at voxel (i,j).
The prior (sijk) is based on two factors: the number of voxels currently
belonging to each cluster (hk), and the prior probability images derived from a











over i = 1...I, j = 1...J and k = 1...K.
(3)
The Bayesian update of the probability is iterated many times until the













The algorithm is terminated when the change in log-likelihood from the
previous iteration becomes negligible. Each iteration of the algorithm involves
estimating the cluster parameters (hk, vk, ck), assigning belonging probabilities
based on the cluster parameters, checking for convergence, and re-estimating
and applying the modulation function. With each iteration, the parameters
describing the distributions move towards a better fit and the belonging prob-
abilities change slightly to reflect the new distributions. Finally, the resulting
probability map is interpreted as the tissue density [20, 21].
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From the three probability maps generated (WM, GM and CSF), BRAIM
assigns each brain pixel to the tissue class with major probability (Figure 3).
The SPM package can also be used for skull stripping.
Figure 3: Brain tissue segmentation results. (a-c) MRI study in axial, sagittal and coronal
planes, respectively, after skull-stripping by the software. (d-f) Probability maps obtained by
gray matter, white matter and cerebrospinal fluid, respectively. (g-i) Segmentation results of
white matter, gray matter and cerebrospinal fluid in axial, sagittal and coronal views, respec-
tively. White matter is depicted in white color, gray matter in light gray, and cerebrospinal
fluid in dark gray.
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3.3. Brain structure segmentation
Basal ganglia structures (putamen, thalamus and caudate nucleus) as well
as hippocampus are detected by means of an interactive polygon tool (Figure
4). This tool lets determine the contour of the structures by selecting the
vertices of the region of interest. There is no need to segment the structure
in each slice since the tool is able to automatically interpolate the contour of
the desired structure in non-consecutive slices, so that the segmentation process
is considerably facilitated. The contour of the structure of interest must be
manually segmented, at least, in the first and in the last slices where it is
visible. Afterwards, Fourier descriptors are used to interpolate the existing
contours between the manually marked contours [22].
Fourier descriptors, also called discrete Fourier transform (DFT) coefficients,
provide a means to represent the boundary of a two-dimensional contour in the
frequency domain as follows. Let xk and yk be the coordinates of a K-point
2D contour for k = {0, 1, 2, ...,K − 1}. Each coordinate pair (xk,yk) can be




−j2piuk/K for u = {0, 1, 2, ...,K − 1}. The coefficients au
are the Fourier descriptors of the boundary. sk can be restored through the












j2piuk/K . Low-frequency components determine global shape
and high-frequency components account for fine detail.
The interpolation between the manually marked contours is based on these
concepts. First, the contours previously segmented are resampled to be a power
of 2 with two goals: to have the same number of points K in both contours
and to make faster the DFT computation. Secondly, the coordinates of the
resampled contours are obtained as s1k = x1k + jy1k and s2k = x2k + jy2k ,
respectively. Then, the 1D DFT of s1k and s2k is computed given a1u and a2u .
Note that {k, u} = {0, 1, 2, ...,K − 1}. Next, the contours of the intermediate
slices are lineally predicted in the frequency domain as aiu = αia1u + βia2u ,
where i = {1, 2, ..., N}, αi = i/N and βi = (N − i)/N , being N the number of
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intermediate contours to be interpolated. Afterwards, aiu is low-filtered with
cutoff at P = K/10, so only 10% of the total number of descriptors, i.e., the
first P descriptors, are taken into account (u = {0, 1, ..., P − 1}). Finally, the
inverse DFT is calculated to convert the intermediate contours to the spatial
domain [23].
Figure 4: Brain structure segmentation results. (a) Axial T1-wi MRI scan of a healthy 23
year-old female. (b) Interactive polygon tool used for determine the putamen vertices for
semi-automatic segmentation. (c) Segmentation results of the putamen in axial plane (green).
(d-f) Semi-automatic segmentation results of putamen (green) and thalamus (blue) in axial,
coronal and sagittal planes obtained with BRAIM.
3.4. Brain lesion segmentation
BRAIM performs a semi-automatic brain lesion segmentation which is based
on 3D watershed transformation [24]. Watershed transformation is a segmenta-
tion technique for gray-scale images. This algorithm is a powerful segmentation
tool whenever the minima of the image represent the objects of interest and the
maxima are the separation boundaries between objects. Due to this fact, the
input image of this method is usually a gradient image. One problem of this
technique is the over-segmentation, which is caused by the existence of numerous
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local minima in the image normally due to the presence of noise. One solution to
this problem is using marker-controlled watershed, in which the markers artifi-
cially indicate the minima of the image. So, to avoid these deficiencies, BRAIM
makes use of the marker-controlled variant. In marker definition not only mark-
ers contained inside the object of interest (internal markers) are needed but also
a marker that determines the image background (external marker). In particu-
lar, BRAIM uses two markers (an internal marker located within the lesion and
an external marker outside of the lesion). The user must select a slice where the
lesion is clearly visible and choose those markers (only two points), the rest of
the lesion segmentation process is completely automatic. The exact location of
the seeds has little influence in the final result. The main steps of the method
can be observed in Figure 5. The main advantage of this method is that it re-
quires little user interaction. Note that BRAIM is designed to be used in clinical
domain and its goal is to make the segmentation process as easier as possible.
For example, an algorithm based on active contours could obtain similar results
but it would require a more accurate initialization (only two points would not
be valid).
The method proposed for lesion segmentation is able to identify different type
of lesions independently of their gray intensity level (tumors as meningiomas,
glioblastomas, cavernomas... or cystic lesions as pineal cysts, arachnoid cysts...).
In Figure 6, an example of the automatic segmentation of a patient diagnosed
with brain Glioblastoma is presented.
3.5. Manual edition tools
BRAIM also provides additional tools for manual edition of the automatic
segmentation results if it is required (pencil tool, paint bucket tool and eraser
tool, see Figure 7). If some manual modification is wanted, it must be performed
previously to volume computation.
3.6. Volume computation
After segmentation, the volume of the lesion and/or the segmented structures
can be directly computed and a 3D model of the brain and the lesion generated.
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Figure 5: Brain lesion segmentation steps. (a) Original MRI. (b) Gradient image. (c) Markers
used in marker-controlled watershed. (d) Final result.
The patient’s brain structure volume results are classified with respect to a
volumetry control database of healthy subjects that is used as a reference. This
comparison allows to better identify brain volume loss, a characteristic feature
of neurodegenerative disorders. In the Results section, more information about
the control database is provided. In the case of brain lesion segmentation, the
volume results obtained can be used in progressive controls for prospective and
retrospective tumor analyses.
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Figure 6: Brain tumor segmentation example in a 53 year-old patient diagnosed with
right frontal lobe Glioblastoma. (a) Axial 3D T1-wi after contrast injection (Gadovist,
0.1mmol/kg). (b-d) Segmentation results in axial, coronal and sagittal planes, respectively.
(e) 3D reconstruction of the segmented lesion where it is possible to see the lesion in a better
detail. Segmentation results showed a total tumor volume of 34.54 cm3.
3.7. Report generator
The report generator tool creates a predesigned report where the patient’s
data (name and age), the study date and the volume results are presented
(tissue, structure and/or lesion volumes, depending on the study type). It is also
possible to show some anatomical images (previously selected by the clinician as
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Figure 7: Manual edition tools for segmentation performance and correction provided by
BRAIM.
more representative) in axial, sagittal and coronal view and the graphs where
brain structure volume results were compared with respect to the volumetry
control database.
4. Results
4.1. Validation of the segmentation methods
For method’s performance evaluation, two public databases were used. Both
databases provide manually segmented images to be used as ground truth.
The performance of the implemented segmentation methods was evaluated
through different concepts in order to quantitatively verify their accuracy. Dice’s
coefficient (D) describes similarity degree between the ground truth and the
segmentation to be evaluated being equal to 1 when segmentation is perfect.
Sensitivity (S), also called true positive fraction, measures the proportion of
positives that are correctly identified as such; it is established by dividing the
correctly classified positive pixels by the total number of positive pixels in the
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gold standard. Positive predictive value (PPV) is the proportion of positive
results that are true positive.
4.1.1. Brain tissue segmentation
The Internet Brain Segmentation Repository (IBSR, https://www.nitrc.
org/projects/ibsr/) and, in particular, the database IBSR V2.0 was used for
the validation of brain tissue segmentation. IBSR V2.0 contains the scans of 18
subjects and the corresponding WM and GM manual segmentations.
Table 1 shows the results obtained by the method proposed for tissue seg-
mentation. Both, automatic results which were obtained directly for the segmen-
tation method and the results obtained after a manual modification to correct
some misclassification, have been included. Manual modification was performed
by an expert neuroradiologist. It can be observed that the automatic results
are quite similar to those obtained after manual modification.
Table 1: Results (mean ± SD) obtained by the method proposed for tissue segmentation
on IBSR V2.0. Dice’s coefficient (D), sensitivity (S) and positive predictive value (PPV).





O Gray matter 0.781 ± 0.078 0.736 ± 0.074 0.836 ± 0.104






D Gray matter 0.781 ± 0.075 0.751 ± 0.076 0.823 ± 0.115
White matter 0.802 ± 0.121 0.757 ± 0.174 0.884 ± 0.068
4.1.2. Brain lesion segmentation
For the validation of brain lesion segmentation, images from BRATS2015
dataset (https://www.smir.ch/BRATS/Start2015) were used. This dataset
belongs to Brain Tumor Image Segmentation Challenge [25]. BRATS2015 is
divided into two subsets: high-grade and low-grade gliomas, HGG and LGG,
respectively. It includes ground truth images which have four different labels:
necrosis, edema, non-enhancing tumor and enhancing tumor. The evaluation is
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done for the tumor core region defined as the union of necrosis, non-enhancing
tumor and enhancing tumor.
In the same way that in Table 1, Table 2 shows the results obtained by
the method proposed for lesion segmentation. Both, automatic results pre and
after manual modification, have been included. It can be observed that the pro-
posed method works better on LGG. In that case, manual modification implies
a greater improvement than in tissue segmentation. It can be caused by the
exiting variability among different lesions. Although, manual modification can
be required in some cases, time saving is considerable if it is compared with a
complete manual lesion segmentation. In addition to the validation shown in
Table 2, a validation based on volume results was also performed. Statistical
results did not show any significant differences between the calculated lesion
volumes from the automated and edited analyses obtained with BRAIM soft-
ware and the ground truth results (data not shown for briefness). This result
suggested that the obtained lesion volumes with BRAIM software were accurate
in all cases.
Table 2: Results (mean ± SD) obtained with the method proposed for lesion segmentation
on BRATS2015 images (high-grade and low-grade gliomas, HGG and LGG). Dice’s coefficient












HGG 0.658 ± 0.111 0.558 ± 0.175 0.920 ± 0.180
LGG 0.685 ± 0.166 0.730 ± 0.209 0.722 ± 0.214







HGG 0.862 ± 0.053 0.832 ± 0.064 0.904 ± 0.091
LGG 0.800 ± 0.081 0.800 ± 0.102 0.820 ± 0.132
HGG + LGG 0.832 ± 0.073 0.817 ± 0.084 0.864 ± 0.118
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4.2. Control database of healthy subjects
The volumetric analyses performed on healthy subjects were used to generate
volume normality curves (Figure 8). There exists a curve for each type of tissue
(WM, GM and CSF) and brain structure (putamen, thalamus, caudate nucleus
and hippocampus). The curves represent the maximum and minimum volume
values for each age range and can be used to classify a subject as normal or not
regarding the volume of their brain tissues and structures. If the volume results
of a new subject fall between the curves, as occurs in the example of the Figure
8, it means that the patient is within the range of normality. If not, tissue and
structure volumes will be outside this range and it will indicate that there is a
brain volume increase or decrease. In some of the experiments of the following
section, this situation will be observed.
Although the initial control database is composed of 50 healthy subjects,
BRAIM allows the constant addition of new data so that the database can be
infinitely increased. The normality curves are automatically updated when new
healthy tissue and structure volumes are included into the control database.
For stablishing a correct database architecture, before incorporating the vol-
ume results into the healthy database, a statistical analysis was performed for
hippocampus and basal ganglia structures. The objective was to rule out the
possibility of interhemispheric volume asymmetries in the healthy population.
Statistical results did not show any significant differences in the volume struc-
tures between hemispheres (data not shown for briefness) and therefore total
volume of both structures was included in the data base as a whole (i.e. total
volume of both thalamus, both caudate nucleus...).
In the selected control participants, brain volume values obtained with BRAIM
CAD system were within the range of normality as described previously in the
literature [26, 27, 28]. The comparative study between sexes showed that males
presented significant higher brain volumes compared to females, reflecting sexual
dimorphism as described previously [29, 30] (see Table 3). Results also showed
the presence of a progressive brain volume loss (as observed in the normality
curves) with age as reported previously [31] (see Figure 9).
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Figure 8: Volume results obtained in a 40 year-old healthy female. (a-b) Representation of
the segmented structures in axial and sagittal planes, respectively. (c-i) Graphs presenting
the subject classification within the healthy control database (x-axis age, y-axis volume) of
the different structures analyzed. Subject’s results are displayed as a big yellow dot. Small
red dots represent the maximum and minimum volume values of the normality range for each
age group. Results showed that the subject was within the normality range when compared
to the control database.
Table 3: Volume results obtained in the control group. Results are expressed as mean ± SD.
p values obtained with a t-student test are shown.
Females (n=25) Males (n=25) p
Total brain volume 1478.96 ± 152.77 1625.34 ± 144.44 0.006
Gray matter 759.25 ± 67.77 830.94 ± 75.85 0.006
White matter 409.05 ± 58.88 452.77 ± 62.4 0.041
CSF 310.64 ± 82.86 341.62 ± 62.69 0.22
4.3. Experiments using BRAIM
In order to evaluate the software performance in some patients and demon-
strate its usefulness, four patients with diagnosed pathologies were selected.
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Figure 9: Volume results obtained in the control group with BRAIM software. Values are
expressed as mean standard deviation. () Total brain volume, (•) gray matter volume, (◦)
white matter volume.
The brain tissues, structures and/or lesions of these patients were segmented
and their volume calculated making use of the tools provided in BRAIM.
4.3.1. Experiment 1: brain tissue and structure volumes
The brain tissue and structure volumes of two patients diagnosed with Mul-
tiple Sclerosis were analyzed (Patients A and B). Patient A presented cognitive
tests suggesting mild cognitive impairment whereas Patient B presented normal
cognitive test results (see Materials and Methods for more information). No sig-
nificant differences were observed with treatment, time of diagnosis, age and sex.
However brain volume results, when they were compared to the healthy control
database, showed brain volume loss in different brain areas that was more sig-
nificant in Patient A. Patient A also presented significant volume loss associated
to hippocampus, a brain structure related to short-term and long-term memory
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and spatial memory and navigation [32, 33]. Therefore, the results obtained
with BRAIM allowed us to detect volume loss, the specific areas affected and
to correlate them with the patient symptoms (see Figures 10 and 11).
Figure 10: Volume results obtained in a 47 year-old female patient diagnosed with Multiple
Sclerosis subtype remitent-recidivant for eleven years (Patient A). (a) Segmented structures
in axial plane. (b-g) Graphs representing the subject classification in the healthy control
database (x-axis age, y-axis volume) of the different structures analyzed. Subject’s results
(big dots in yellow) showed the presence of significant volume loss affecting white and gray
matter, thalamus, hippocampus, putamen and caudate nucleus.
Figure 11: Volume results obtained in a 48 year-old female patient diagnosed with Multiple
Sclerosis subtype remitent-recidivant for fourteen years (Patient B). (a) Segmented structures
in axial plane. (b-g) Graphs representing the subject classification in the healthy control
database (x-axis age, y-axis volume) of the different structures analyzed. Subject’s segmenta-
tion results (big dots in yellow) only showed the presence of significant volume loss affecting
thalamus, putamen and caudate nucleus.
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4.3.2. Experiment 2: brain lesion volumes
The lesion volume of other two patients diagnosed with brain tumors (Pa-
tients C and D) were also analyzed with the presented CAD system. Lesion
segmentation with BRAIM software allowed us to obtain a robust and precise
measurement of the lesion burden in the patients. Segmentation was performed
automatically with BRAIM and manually corrected in case necessary by an
experienced researcher (A.B-S).
Figure 12 displays the volume results of a 25 year-old female patient diag-
nosed with a pontine tumor. Because of the lesion location surgery was avoided
and an experimental treatment with Chemotherapy was applied. MRI was per-
formed to better control the treatment efficacy. As it is shown in the graph, the
treatment let a significant tumor reduction, which was related to a clinical im-
provement (diplopia), being the patient at the moment clinically stable. These
results allowed us to precisely calculate the tumor reduction after treatment and
to better monitor the treatment efficacy.
Figure 13 shows the segmentation results obtained in a 27 year-old male
patient diagnosed with an astrocitoma III. The tumor affected both frontal
lobes and corpus callosum. Complete tumor surgery was not possible because
of the lesion location and extension. After definite diagnose with histopathology,
Radiotherapy and Chemotherapy were administrated to the patient. The graph
shows the lesion evolution with time and treatment. As it can be seen, the lesion
was significantly reduced with treatment, however after last surgery (month
27) there was a worsening of the patient symptoms with a significant lesion
volume increase (month 43). Histopathology results showed that the lesion had
transformed to a Glioblastoma (grade IV tumor).
5. Discussion
As mentioned before, BRAIM is able to segment brain tissues, structures
and/or lesions in addition to perform volumetric analyses. One of the main
advantages of the software is that it is easy to use and could be operated in a
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Figure 12: Lesion volume results obtained with BRAIM CAD system in a 25 year-old female
diagnosed with a pontine tumor (Patient C). Biopsy was not performed because of the lesion
location. Chemotherapy was applied in order to control tumor growth. MRI scans were
performed for lesion control and treatment efficacy monitoring. MR images on the graphs
(axial T1-wi after contrast injection) display the lesion at the beginning of the treatment
(23.74 cm3), the lesion after two sessions of chemotherapy (11.66 cm3) and the last control
performed after three chemotherapy sessions (3.52 cm3). Chemotherapy treatments are shown
in the graph as arrows.
common PC with a Windows operating system. Comparing to other similar pro-
grams e.g. SPM, FSL, FreeSurfer (available through fil.ion.ucl.ac.uk/spm/
software/spm12; fsl.fmrib.ox.ac.uk/fsldownloads/; freesurfer.net/; re-
spectively) its use do not require the installation of additional software, MAT-
LAB, virtual machines or programming knowledge, which makes easier its use
in the clinical setting. Segmentations are performed in a very intuitive an easy
way, and the results are robust and reproducible. In particular, little user in-
teraction is needed for lesion and structure segmentation. In the case of lesion
segmentation, the interaction is reduced to the only selection of two points, a
point within the lesion and other outside, as it was explained in Subsection 3.4.
Structure segmentation requires a bit more interaction, the user must determine
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Figure 13: Lesion volume results obtained with BRAIM software in a 27 year-old male di-
agnosed with astrocitoma III after biopsy (Patient D). The lesion was affecting both frontal
lobes and corpus callosum. Initial volume was 113 cm3, after partial surgery the lesion vol-
ume was of 39 cm3, suggesting that the 65% of the lesion was removed. Chemotherapy
(CHT) and Radiotherapy (RT) were applied in order to control the rest tumor growth. MRI
scans were performed for lesion control and treatment efficacy monitoring. MR images on the
graphs (axial FLAIR for better visualization of the lesion extension because the lesion did
not present contrast enhancement) display the initial lesion, the lesion after two sessions of
CHT and one session of RT (14.1 cm3) and the last control performed after a second surgery
and a chemotherapy session (33.4 cm3). Chemotherapy treatments are shown in the graph as
arrows, surgery is shown as a star and RT is shown as a triangle.
by means of mouse clicks the vertices of the structure of interest, at least, in
the first and in the last slice of the MRI volume where the structure is visible
(see Subsection 3.3 for more details). In addition, the results of BRAIM could
be always manually corrected in case they are not satisfactory through edition
tools such as pencil tool, paint bucket and eraser tool. This is a very impor-
tant feature of the software and constitutes a main advantage respect to other
software since it avoids that some patients could not be included in the study
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because of problems with the segmentation algorithms. Thus, BRAIM allows
to a more efficient use of the data and prevents data loss.
The software performance was tested and the system was used to generate a
volumetry control database. Even with only a database of 50 healthy subjects,
the analysis preformed in patients diagnosed with neurodegenerative disorders
allowed us to detect brain volume loss as well as local differences (related to brain
structures) that were related to clinical symptoms. In addition, the system was
able to classify the patient within the database providing objective results. In
oncology patients, the results presented a good correlation with the treatment
application and patient evolution; allowing us to better predict the outcome.
The presence of an internal control database is extremely useful as it allows to
detect brain volume changes in the patients more efficiently. To our knowledge
there is not at the moment any other software available that allows a direct
patient classification within an internal control database. In this context, it is
important to note that the software is able to compare and classify different
brain areas. The results are shown in a simple and intuitive graph system
allowing a fast classification of the patients between normal or pathological.
Moreover, the ability to detect volume loss in specific brain areas is also of value,
as it has been shown that different neurodegenerative diseases present different
neurodegenerative patterns [34, 35, 36]. Therefore, BRAIM results could be
used in the clinical setting as a complementary tool to more precisely diagnose
brain volume loss or confirm a diagnosis when there is a clinical suspicion of a
specific disease.
Overall, BRAIM software allowed us to obtain in a fast and simple way,
information that is not currently available by conventional MRI clinical proce-
dures. According to our preliminary results, we believe that the information
provided by the software may be extremely useful in the clinical setting for a
better patient management and treatment monitoring.
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6. Conclusions
In this paper, BRAIM, a new CAD system for brain pathologies diagnosis
and monitoring was presented. The software is featured with different user-
friendly tools to help clinicians in brain segmentation and volume computation.
Specifically, BRAIM allows to perform segmentation and volume measurement
of white, gray matter and cerebrospinal fluid; basal ganglia structures and hip-
pocampus; as well as brain lesions. Tissue and lesion segmentations are com-
pletely automatic although they can be manually corrected if needed. Brain
structures segmentations are semi-automatic and need that an expert select the
vertices of the structures in their initial and final slice.
BRAIM software presents numerous advantages for clinicians, as it is fast,
robust and easy to work with. From this perspective, it is expected its progres-
sive incorporation in the clinical setting as a tool to help diagnosis and optimal
patient monitoring.
In future work, a larger test of the application on more pathological patients
will be done. The volumetry control database will also be continually increased.
Finally, exhaustive work will be performed for brain structure segmentation by
means of completely automatic methods.
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Appendix A. Main methods of BRAIM
Table A.4 enumerates the main methods included in BRAIM along with the
main functions or classes used in each method and their corresponding libraries.
Note that for the development of the methods that make use of the ITK, VTK
and Qt libraries, the mentioned functions were invoked from own code and
combined with other own algorithms.
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